Analysts have recently shared mixed opinions on several healthcare stocks, including Insulet (PODD), UnitedHealth (UNH), and Ottobock SE & Co. KGaA (OBCKF). Robert W. Baird analyst Jeff Johnson downgraded Insulet to Hold with a price target of $158.00, noting the stock closed last Thursday at $137.23. Johnson, a 5-star analyst with a 9.7% average return, covers healthcare stocks like Zimmer Biomet Holdings and Beta Bionics.
UnitedHealth received a Buy rating and a $455.00 price target from TD Cowen analyst Ryan Langston. The stock closed last Thursday at $330.48. Langston, a 3-star analyst with a 1.1% average return, focuses on healthcare stocks such as Alignment Healthcare and Acadia Healthcare. The consensus on UnitedHealth is a Strong Buy with an average price target of $486.00, suggesting a 38.4% upside.
Henrik Paganetty from Jefferies maintained a Buy rating on Ottobock SE & Co. KGaA with a price target of EUR83.00. The current analyst consensus for Ottobock is a Strong Buy, but the average price target of $73.69 indicates a -99.1% downside from current levels. Deutsche Bank also maintained a Buy rating with a EUR56.00 price target.